Development of Radioligand Therapy-Responsive Syngeneic Prostate Models through Murine Prostate-Specific Membrane Antigen Point Mutation
{{output}}
Robust, reproducible, and meaningful research requires suitable murine preclinical models that effectively mimic the disease and possess a functional immune system. In the context of metastatic castration-resistant prostate cancer (mCRPC) studies and with all ... ...
